A comparison between the blood concentration of oral midazolam for the pediatric preanesthetic medication and sedative effect

A comparison between the blood concentration of oral midazolam for the pediatric preanesthetic medication and sedative effect - A comparison between the blood concentration of oral MDZ for the pediatric preanesthetic medication and sedative effect

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046068

Enrollment

200

Registered

2021-11-15

Start date

2017-09-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia cases between 6 months and 8 years old

Interventions

Administration of MDZ syrup (in-house formulation)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients receiving MDZ syrup as pre-anesthetic medication before surgery

Exclusion criteria

Exclusion criteria: Patients with a history of hypersensitivity to MDZ components or MDZ excipients Patients who did not give consent for this study

Design outcomes

Primary

Measure	Time frame
Sedation score (Wilton's behavior score) Midazolam blood concentration	—

Countries

Japan

Contacts

Public ContactMatsuda Hiromi

Kitasato University School of Medicine Department of Anesthesiology

mtdhrm0615@yahoo.co.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026